Wastewater Pathogen Variant Analytics Global Market Report 2026

The wastewater pathogen variant analytics market size has grown rapidly in recent years. It will grow from $1.62 billion in 2025 to $1.9 billion in 2026 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to growing awareness of community-level disease monitoring, adoption of pcr-based pathogen detection, rising municipal wastewater testing, development of environmental monitoring labs, increased funding for public health surveillance.

The wastewater pathogen variant analytics market size is expected to see rapid growth in the next few years. It will grow to $3.63 billion in 2030 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to expansion of next-generation sequencing technologies, integration with ai and big data analytics, increased government initiatives for outbreak prediction, demand for real-time wastewater monitoring, collaboration between municipalities and research institutes. Major trends in the forecast period include wastewater genomic surveillance, real-time pathogen variant tracking, ai-powered outbreak prediction, integration with public health dashboards, predictive environmental risk analytics.

The rising prevalence of infectious diseases is expected to propel the growth of the wastewater pathogen variant analytics market in the coming years. Infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly among populations. The growing burden of infectious diseases is driven by factors such as increased global travel, urbanization, and higher risks of cross-border transmission, which accelerate the spread of emerging and re-emerging pathogens. Wastewater pathogen variant analytics address this challenge by enabling early detection of pathogens and their variants at the community level, allowing faster public health responses and targeted interventions to limit transmission. For instance, in February 2026, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that seasonal influenza in the United States caused approximately 290,000-450,000 hospitalizations and 34,000-53,000 deaths annually, while respiratory syncytial virus (RSV) accounted for an estimated 190,000-350,000 hospitalizations and 10,000-23,000 deaths. Therefore, the rising prevalence of infectious diseases is driving the growth of the wastewater pathogen variant analytics market.

Key companies operating in the wastewater pathogen variant analytics market are increasingly focusing on technological advancements in advanced molecular diagnostics platforms to enhance detection accuracy, improve real-time pathogen surveillance, and support early identification of emerging public health threats. Molecular diagnostic technologies use nucleic-acid-based methods, such as PCR and sequencing, to detect and quantify DNA or RNA from pathogens in complex samples, including wastewater. For example, in April 2025, bioMérieux, a France-based company involved in in-vitro diagnostics, launched WATCHFIRE, an innovative molecular testing solution designed to strengthen wastewater pathogen surveillance through rapid, multiplex PCR detection of up to 22 respiratory pathogens directly from sewage influent samples. The system delivers results in approximately 45 minutes and integrates with FIREWORKS software to enable real-time trend analysis and automated alerts, supporting early warning and outbreak monitoring. WATCHFIRE runs on the BIOFIRE FILMARRAY TORCH instrument, enabling decentralized, near-source testing with minimal hands-on time, and is expected to expand later in the year to include a gastrointestinal panel, broadening pathogen coverage and complementing sequencing-based variant analytics for public health authorities.

In October 2023, Verily Life Sciences LLC, a US-based precision health technology company providing wastewater surveillance services, laboratory analysis, and data science solutions, partnered with the U.S. Centers for Disease Control and Prevention (CDC) to support the National Wastewater Surveillance System (NWSS) by offering nationwide wastewater testing for pathogen detection, including SARS-CoV-2 and MPXV. Through this collaboration, Verily aims to enhance public health surveillance capabilities and expand its presence in real-time wastewater epidemiology to generate actionable data for outbreak detection and disease trend analysis. The U.S. Centers for Disease Control and Prevention (CDC) is a US-based national public health institute responsible for disease control, prevention programs, public health guidance, and surveillance systems to protect public health and safety.

Major companies operating in the wastewater pathogen variant analytics market are Roche Diagnostics International Ltd., Thermo Fisher Scientific Inc., SGS SA, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., BioMérieux SA, IDEXX Laboratories Inc., Bio-Rad Laboratories, QIAGEN N.V., ALS Limited, Promega Corporation, Ginkgo Bioworks Inc., Oxford Nanopore Technologies plc, LuminUltra Technologies Ltd., Verily Life Sciences LLC, Zymo Research Corp., PathogenDx Inc., Clear Labs Inc., GT Molecular Inc.

North America was the largest region in the wastewater pathogen variant analytics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the wastewater pathogen variant analytics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the wastewater pathogen variant analytics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The wastewater pathogen variant analytics market includes revenues earned by providing services such as epidemiological modeling and outbreak forecasting services, customized assay development services, regulatory compliance and validation services, predictive hotspot identification services, emergency outbreak surge testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The wastewater pathogen variant market consists of sales of portable field-deployable molecular testing devices, smart sewer network monitoring sensors, mutation frequency quantification modules, automated liquid handling robotic systems, metagenomic library preparation automation kits. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Wastewater pathogen variant analytics involves examining genetic material from pathogens present in wastewater to detect, track, and monitor different variants or strains circulating within a community. By sequencing and analyzing pathogen genomes shed in human waste, this method provides early warnings of outbreaks, monitors the emergence and spread of new variants, and supports public health surveillance without relying solely on clinical testing.

The key pathogen types in wastewater pathogen variant analytics include viruses, bacteria, parasites, and fungi. Viruses are monitored to detect, track, and analyze pathogen variants in wastewater, supporting public health responses and environmental safety measures. They leverage technologies such as polymerase chain reaction (PCR)-based methods, next-generation sequencing, immunoassays, biosensors, and others. Applications include public health surveillance, environmental monitoring, industrial wastewater, municipal wastewater, and more, serving municipalities, research institutes, industrial facilities, healthcare facilities, and other end-users.

Tariffs have affected the wastewater pathogen variant analytics market by increasing the cost of importing advanced sequencing instruments, biosensors, and reagents. Segments such as next-generation sequencing and biosensors are most impacted, particularly in regions like North America and Europe that depend on imported high-tech equipment. While these tariffs pose challenges, they are encouraging local manufacturing and innovation in cost-effective monitoring technologies, supporting the growth of domestic production and resilience in the market.

The wastewater pathogen variant analytics market research report is one of a series of new reports that provides wastewater pathogen variant analytics market statistics, including wastewater pathogen variant analytics industry global market size, regional shares, competitors with a wastewater pathogen variant analytics market share, detailed wastewater pathogen variant analytics market segments, market trends and opportunities, and any further data you may need to thrive in the wastewater pathogen variant analytics industry. This wastewater pathogen variant analytics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.